Grow your business safely with 2N PHARMACIES

All the information you need about 2N PHARMACIES to develop and secure your business in France

2 HOME > CORPORATES > 2N PHARMACIES > BALANCE SHEET ( 2020-07-23)

THE LIST OF BALANCE SHEET : 2N PHARMACIES

CORPORATEBOBACCESTABLISHMENTSMANAGERSFINANCE
Deposit Confidentiality closing date document
2023-03-16 Public 2021-12-31 Complete
2021-04-27 Public 2019-12-31 Complete
2020-07-23 Public 2018-12-31 Complete
2019-07-01 Public 2017-12-31 Complete
2017-08-29 Public 2016-12-31 Complete
2017-05-10 Public 2014-12-31 Complete
Name2N PHARMACIES
Siren805313178
Closing2018-12-31
Registry code 3302
Registration number 12468
Management number2014D01544
Activity code 6420Z
Closing date n-12017-12-31
Duration Fiscal year 12
Duration Fiscal year n-112
Filing date2020-07-23
Modification01 Annual accounts entered with accounting inconsistencies at document source
Balance sheet typeC : Complete
Currency codeEUR
ConfidentialityPublic
Address33000 Bordeaux
1 - Assets (balance sheet)Gross amount year NAmortization year NNet year NNet year N-1
AB Establishment Expenses 21 255.00 17 748.00 3 507.00 21 255.00
BJ TOTAL (I) 561 504.00 17 748.00 543 756.00 561 504.00
BZ Other receivables 67 918.00 67 918.00 67 918.00
CF Cash and cash equivalents 910.00 910.00 910.00
CJ TOTAL (II) 68 828.00 68 828.00 68 828.00
CO Grand total (0 to V) 630 332.00 17 748.00 612 584.00 630 332.00
CS Evaluated investments - equity method 540 249.00 540 249.00 540 249.00
2 - Liabilities (balance sheet)Amount year NAmount year N-1
DA Share or individual capital 100.00 100.00 100.00
DD Legal reserve (1) 10.00 10.00 10.00
DG Other reserves 92 637.00 105 425.00 92 637.00
DI RESULTS FOR THE YEAR (Profit or Loss) 81 714.00 -12 788.00 81 714.00
DL TOTAL (I) 174 461.00 92 747.00 174 461.00
DU Loans and Debts from Credit Institutions (3) 312 624.00 325 097.00 312 624.00
DV Miscellaneous Loans and Financial Debts (4) 125 299.00 144 651.00 125 299.00
DX Trade payables and related accounts 200.00 600.00 200.00
EA Other liabilities 218.00
EC TOTAL (IV) 438 123.00 470 565.00 438 123.00
EE Grand total (I to V) 612 584.00 563 312.00 612 584.00
3 - Income statementAmount France year NAmount Export year NTotal year NTotal year N-1
FW Other purchases and external expenses 602.00
FX Taxes, duties, and similar payments
GB Operating Expenses - Provisions 4 251.00
GF Total Operating Expenses (II) 4 853.00
GG - OPERATING RESULT (I - II) -4 853.00
GP Total financial income (V) 67 500.00
GU Total financial expenses (VI) 8 410.00
GV - FINANCIAL INCOME (V - VI) 59 090.00
GW - CURRENT INCOME BEFORE TAX (I - II + III - IV + V - VI) 54 237.00
4 - Income statement (continued)Amount year NAmount year N-1
HD Total exceptional income (VII) 27 502.00 27 502.00
HH Total exceptional expenses (VIII) 25.00 93.00 25.00
HI - EXCEPTIONAL RESULT (VII - VIII) 27 477.00 -93.00 27 477.00
HL TOTAL REVENUE (I + III + V + VII) 95 002.00 1.00 95 002.00
HM TOTAL EXPENSES (II + IV + VI + VIII + IX + X) 13 288.00 12 789.00 13 288.00
HN PROFIT OR LOSS (Total revenue - Total expenses) 81 714.00 -12 788.00 81 714.00
6 - Depreciation Amount at beginning of yearIncrease: allocation for the yearDiminution repriseYear-end amount
0N DEPRECIATION Grand Total 13 497.00 4 251.00 13 497.00
PE DEPRECIATION Total including other intangible assets 13 497.00 4 251.00 13 497.00
8 - Receivables and payablesGross amountAmount within 1 yearAmount 1 to 5 yearsAmount more than 5 years
8B Suppliers and Related Accounts 200.00 200.00 200.00
VH Loans with a maturity of more than one year at origin 312 624.00 32 300.00 135 438.00 312 624.00
VI Group and Associates 125 299.00 125 299.00 125 299.00
VJ Loans taken out during the year 8 948.00 8 948.00
VK Loans repaid during the year 17 652.00 17 652.00
VR Miscellaneous debtors (including receivables related to repo transactions) 67 918.00 67 918.00 67 918.00
VT TOTAL – STATEMENT OF RECEIVABLES 67 918.00 67 918.00 67 918.00
VY TOTAL – STATEMENT OF LIABILITIES 438 123.00 157 799.00 135 438.00 438 123.00

all companies in France

Complete and comprehensive database.